179 related articles for article (PubMed ID: 31655919)
1. Correction to: The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
Zheng L; Li X; Gu Y; Lv X; Xi T
Breast Cancer Res Treat; 2020 Jan; 179(2):521-522. PubMed ID: 31655919
[TBL] [Abstract][Full Text] [Related]
2. The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
Zheng L; Li X; Gu Y; Lv X; Xi T
Breast Cancer Res Treat; 2015 Feb; 150(1):105-18. PubMed ID: 25701119
[TBL] [Abstract][Full Text] [Related]
3. Competing endogenous RNA networks of CYP4Z1 and pseudogene CYP4Z2P confer tamoxifen resistance in breast cancer.
Zheng L; Li X; Meng X; Chou J; Hu J; Zhang F; Zhang Z; Xing Y; Liu Y; Xi T
Mol Cell Endocrinol; 2016 May; 427():133-42. PubMed ID: 26980484
[TBL] [Abstract][Full Text] [Related]
4. Pseudogene CYP4Z2P 3'UTR promotes angiogenesis in breast cancer.
Zheng L; Li X; Gu Y; Ma Y; Xi T
Biochem Biophys Res Commun; 2014 Oct; 453(3):545-51. PubMed ID: 25281903
[TBL] [Abstract][Full Text] [Related]
5. Correction to: Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.
Zheng L; Guo Q; Xiang C; Liu S; Jiang Y; Gao L; Ni H; Wang T; Zhao Q; Liu H; Xing Y; Wang Y; Li X; Xi T
J Hematol Oncol; 2019 Oct; 12(1):109. PubMed ID: 31651345
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.
Zheng L; Guo Q; Xiang C; Liu S; Jiang Y; Gao L; Ni H; Wang T; Zhao Q; Liu H; Xing Y; Wang Y; Li X; Xi T
J Hematol Oncol; 2019 Mar; 12(1):23. PubMed ID: 30832689
[TBL] [Abstract][Full Text] [Related]
7. Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.
Hutcheson IR; Knowlden JM; Hiscox SE; Barrow D; Gee JMW; Robertson JF; Ellis IO; Nicholson RI
Breast Cancer Res; 2018 Aug; 20(1):98. PubMed ID: 30165904
[TBL] [Abstract][Full Text] [Related]
8. The competing endogenous RNA network of CYP4Z1 and pseudogene CYP4Z2P exerts an anti-apoptotic function in breast cancer.
Li C; Zheng L; Xin Y; Tan Z; Zhang Y; Meng X; Wang Z; Xi T
FEBS Lett; 2017 Apr; 591(7):991-1000. PubMed ID: 28236635
[TBL] [Abstract][Full Text] [Related]
9. CYP4Z1 3'UTR represses migration of human breast cancer cells.
Wang B; Zheng L; Chou J; Li C; Zhang Y; Meng X; Xi T
Biochem Biophys Res Commun; 2016 Sep; 478(2):900-7. PubMed ID: 27520371
[TBL] [Abstract][Full Text] [Related]
10. Correction: Calcium sensing receptor protects high glucose-induced energy metabolism disorder via blocking gp78-ubiquitin proteasome pathway.
Wang Y; Gao P; Wei C; Li H; Zhang L; Zhao Y; Wu B; Tian Y; Zhang W; Wu L; Wang R; Xu C
Cell Death Dis; 2020 Sep; 11(9):784. PubMed ID: 32958752
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum to "Pseudogene CYP4Z2P 3'UTR promotes angiogenesis in breast cancer." [Biochem. Biophys. Res. Commun. 2014 oct 24, 453(3), 545-51].
Zheng L; Li X; Gu Y; Ma Y; Xi T
Biochem Biophys Res Commun; 2020 Jan; 521(2):546-547. PubMed ID: 31672276
[No Abstract] [Full Text] [Related]
12. Author Correction: Caveolin-1 promotes invasion and metastasis by upregulating Pofut1 expression in mouse hepatocellular carcinoma.
Zhang C; Huang H; Zhang J; Wu Q; Chen X; Huang T; Li W; Liu Y; Zhang J
Cell Death Dis; 2019 Jul; 10(8):572. PubMed ID: 31358729
[TBL] [Abstract][Full Text] [Related]
13. Correction: Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis.
Wei X; Liu Y; Gong C; Ji T; Zhou X; Zhang T; Wan D; Xu S; Jin P; Yang X; Li X; Ma D; Yang Z; Gao Q
Anticancer Agents Med Chem; 2019; 19(1):140-142. PubMed ID: 31204622
[TBL] [Abstract][Full Text] [Related]
14. The
Hu J; Li X; Guo X; Guo Q; Xiang C; Zhang Z; Xing Y; Xi T; Zheng L
J Cell Sci; 2017 Oct; 130(19):3399-3413. PubMed ID: 28818997
[TBL] [Abstract][Full Text] [Related]
15. [Corrigendum] Lycorine inhibits cell proliferation and migration by inhibiting ROCK1/cofilin‑induced actin dynamics in HepG2 hepatoblastoma cells.
Liu W; Zhang Q; Tang Q; Hu C; Huang J; Liu Y; Lu Y; Wang Q; Li G; Zhang R
Oncol Rep; 2019 Dec; 42(6):2856. PubMed ID: 31638240
[TBL] [Abstract][Full Text] [Related]
16. [Corrigendum] Preventive effect of caffeine and curcumin on hepato-carcinogenesis in diethylnitrosamine-induced rats.
Fujise Y; Okano J; Nagahara T; Abe R; Imamoto R; Murawaki Y
Int J Oncol; 2016 Sep; 49(3):1259. PubMed ID: 27314753
[TBL] [Abstract][Full Text] [Related]
17. Author Correction: Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling.
Usman MW; Gao J; Zheng T; Rui C; Li T; Bian X; Cheng H; Liu P; Luo F
Cell Death Dis; 2019 Jun; 10(7):501. PubMed ID: 31235854
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma.
Rieger MA; Ebner R; Bell DR; Kiessling A; Rohayem J; Schmitz M; Temme A; Rieber EP; Weigle B
Cancer Res; 2004 Apr; 64(7):2357-64. PubMed ID: 15059886
[TBL] [Abstract][Full Text] [Related]
19. [Corrigendum] High expression of RELM-α correlates with poor prognosis and promotes angiogenesis in gastric cancer.
Chen P; Zhao D; Wang W; Zhang Y; Yuan Y; Wang L; Wu Y
Oncol Rep; 2019 Mar; 41(3):2067. PubMed ID: 30569157
[TBL] [Abstract][Full Text] [Related]
20. [Corrigendum] USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β‑catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
Int J Oncol; 2019 Nov; 55(5):1176. PubMed ID: 31485660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
